068270:KRX
Celltrion Inc
â‚©211,000.00
arrow_downward
-1.86%(-4,000.00) 1D
Nov 6, 3:30:29 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 068270...
Open
â‚©205,000
High
â‚©214,500
Low
â‚©203,500
Mkt. cap
48.97T
Avg. vol.
519.10K
Volume
1.04M
Dividend
0.34%
Quarterly dividend
â‚©179
Ex-dividend date
Dec 29, 2025
P/E ratio
30.84
52-wk high
â‚©239,047
52-wk low
â‚©158,500
EPS
â‚©6,842
Shares outstanding
232.07M
No. of employees
3K
Open
â‚©205,000
High
â‚©214,500
Low
â‚©203,500
Mkt. cap
48.97T
Avg. vol.
519.10K
Volume
1.04M
Dividend
0.34%
Quarterly dividend
â‚©179
Ex-dividend date
Dec 29, 2025
P/E ratio
30.84
52-wk high
â‚©239,047
52-wk low
â‚©158,500
EPS
â‚©6,842
Shares outstanding
232.07M
No. of employees
3K
News stories
From web sources and news partners
Korea JoongAng Daily
·
16 hours ago
Celltrion nears annual target on biosimilar surge
Profile
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
About Celltrion Inc
CEOWoosung Kee
Employees2.96K
Founded2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecelltrion.com